Key facts
- It has raised $200K; the latest was Angel (individual) ($200K) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Experitas
- ·The full record, as it builds
Funding rounds
No funding rounds for Experitas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Experitas
Developer of a medical case screening platform designed to evaluate malpractice claims. The company's platform utilizes licensed physicians with advanced AI, a compliant platform that delivers standard of care assessments and case merit determinations, enabling law firms, state medical boards, and hospital medical boards to evaluate physician complaints and adverse outcomes.
- Sector
- Information Technology
- HQ
- Portland, OR, United States
- Founded
- 2025
- Website
- experitas.com/
- Ownership
- Privately Held (backing)
Experitas doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Experitas shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Experitas in its N-PORT filings yet. We sweep new filings monthly.